A detailed history of Ica Group Wealth Management, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Ica Group Wealth Management, LLC holds 1,600 shares of MCRB stock, worth $1,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,600
Holding current value
$1,152
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.75 - $1.56 $1,200 - $2,496
1,600 New
1,600 $1,000
Q2 2023

Aug 11, 2023

BUY
$4.67 - $6.55 $350 - $491
75 New
75 $0

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Ica Group Wealth Management, LLC Portfolio

Follow Ica Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ica Group Wealth Management, LLC with notifications on news.